Complementary and alternative therapies for cancer

BR Cassileth, G Deng - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the differences between complementary and alternative therapies. List common …

Treatments for astrocytic tumors in children: current and emerging strategies

SR Burzynski - Pediatric Drugs, 2006 - Springer
Strategies for the treatment of childhood cancer have changed considerably during the last
50 years and have led to dramatic improvements in long-term survival. Despite these …

[PDF][PDF] The present state of antineoplaston research (1)

SR Burzynski - Integrative Cancer Therapies, 2004 - journals.sagepub.com
Antineoplastons work as molecular switches, which regulate expression of genes p53 and
p21 through demethylation of promoter sequences and acetylation of histones. They also …

[PDF][PDF] Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma

SR Burzynski, TJ Janicki, RA Weaver… - Integrative Cancer …, 2006 - journals.sagepub.com
Background: Brainstem glioma carries the worst prognosis of all malignancies of the brain.
Most patients with brainstem glioma fail standard radiation therapy and chemotherapy and …

[PDF][PDF] Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1

SR Burzynski, RA Weaver, T Janicki… - Integrative Cancer …, 2005 - journals.sagepub.com
Primitive neuroectodermal tumors (PNETs) are usually successfully treated with craniospinal
radiation and chemotherapy; however, difficulties with standard treatment can be …

Central nervous system tumors

LS Ashby, MM Troester, WR Shapiro - Update on Cancer Therapeutics, 2006 - Elsevier
INTRODUCTION: Chemotherapy, immunotherapy, and biological response modifiers were
tested in clinical trials for brain tumors. Results of these studies published in 2003 and 2004 …

[PDF][PDF] Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme

SR Burzynski, RI Lewy, R Weaver… - Integrative Cancer …, 2004 - journals.sagepub.com
Recurrent diffuse intrinsic brain stem glioblastoma multiforme carries an extremely poor
prognosis and a median survival of less than 7 months. In this article, the authors report …

Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma: a preliminary report

SR Burzynski, RA Weaver, RI Lewy, TJ Janicki… - Drugs in R & D, 2004 - Springer
Objective: To evaluate the response rates, survival and toxicity of treatment with
antineoplaston A10 and AS2-1 (ANP) in the first 12 children enrolled in our studies …

[HTML][HTML] Stanislaw Burzynski: four decades of an unproven cancer cure

DH Gorski - Skeptical Inquirer, 2014 - skepticalinquirer.org
The Houston doctor Stanislaw Burzynski has been using an unproven cancer
cure,“antineoplastons,” for decades, but despite its lack of proven anticancer activity, he has …

[HTML][HTML] СРЕДСТВА АЛЬТЕРНАТИВНОЙ ЛЕКАРСТВЕННОЙ ТЕРАПИИ РАКА: АНТИНЕОПЛАСТОНЫ-ПРОТИВООПУХОЛЕВЫЕ СВОЙСТВА И МЕХАНИЗМЫ …

ДБ Корман - Вопросы онкологии, 2014 - voprosyonkologii.ru
Аннотация В обзоре проанализированы опубликованные в медицинской литературе
данные о противоопухолевых свойствах антинеопласто-нов-средств альтернативной …